Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial. - Wikidata - wikimedia - TriplyDB

Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial.

Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial.

http://www.wikidata.org/entity/Q33886896

about

Atrial fibrillation therapy now and in the future: drugs, biologicals, and ablation Electrophysiological Perspectives on Hybrid Ablation of Atrial Fibrillation.Who Needs Catheter Ablation And Which Approach?Elimination Of Triggers Without An Additional Substrate Modification Is Not Sufficient In Patients With Persistent Atrial Fibrillation Predictors of Recurrence After Catheter Ablation of Persistent Atrial Fibrillation Staged transthoracic approach to persistent atrial fibrillation (TOP-AF): study protocol for a randomized trial.Safety and efficacy of switching anticoagulation to aspirin three months after successful radiofrequency catheter ablation of atrial fibrillation.Pulmonary vein isolation with complex fractionated atrial electrogram ablation for paroxysmal and nonparoxysmal atrial fibrillation: A meta-analysis Efficacy of adjunctive ablation of complex fractionated atrial electrograms and pulmonary vein isolation for the treatment of atrial fibrillation: a meta-analysis of randomized controlled trials.Improving ablation strategies for the treatment of atrial fibrillation.Interventional treatment of atrial fibrillation - contemporary methods and perspectives.Does additional linear ablation after circumferential pulmonary vein isolation improve clinical outcome in patients with paroxysmal atrial fibrillation? Prospective randomised study.The role of fibroblasts in complex fractionated electrograms during persistent/permanent atrial fibrillation: implications for electrogram-based catheter ablation.Cryoballoon ablation for atrial fibrillation.eNOS3 Genetic Polymorphism Is Related to Post-Ablation Early Recurrence of Atrial Fibrillation.Current issues in atrial fibrillation.Atrial Substrate Modification in Atrial Fibrillation: Targeting GP or CFAE? Evidence from Meta-Analysis of Clinical Trials.Arrhythmia Termination Versus Elimination of Dormant Pulmonary Vein Conduction as a Procedural End Point of Catheter Ablation for Paroxysmal Atrial Fibrillation: A Prospective Randomized Trial Ablating persistent atrial fibrillation successfully.Clinical Significance of Additional Ablation of Atrial Premature Beats after Catheter Ablation for Atrial Fibrillation.Mechanisms of Atrial Fibrillation - Reentry, Rotors and Reality Minimizing discordances in automated classification of fractionated electrograms in human persistent atrial fibrillation.Challenging Achievement of Bidirectional Block After Linear Ablation Affects the Rhythm Outcome in Patients With Persistent Atrial Fibrillation.Necessity of Repeat Ablations to Eliminate Atrial Fibrillation.Comparing Safety and Efficacy of Irrigated Radiofrequency Catheter Ablation Versus Combined Cryoballoon and Catheter Ablation for Persistent Atrial Fibrillation.A Thin Left Atrial Antral Wall Around the Pulmonary Vein Reflects Structural Remodeling by Atrial Fibrillation and is Associated with Stroke.Early recurrence of atrial tachyarrhythmias following radiofrequency catheter ablation of atrial fibrillation.Efficacy of cardiac autonomic denervation for atrial fibrillation: a meta-analysis.Current hot potatoes in atrial fibrillation ablation.Venice Chart international consensus document on atrial fibrillation ablation: 2011 update.Comparative effectiveness of catheter ablation strategies for rhythm control in patients with atrial fibrillation: a meta-analysis.Contemporary approaches to persistent atrial fibrillation.Update on atrial fibrillation catheter ablation technologies and techniques.Catheter ablation of persistent atrial fibrillation.Catheter Ablation of Atrial Fibrillation to Maintain Sinus Rhythm.Unanswered Questions in Complex Fractionated Atrial Electrogram Ablation.New Insights On Ablation Of Persistent Atrial Fibrillation: Evidence From The SARA Trial.The burden of proof: The current state of atrial fibrillation prevention and treatment trials.Adjunctive ablation strategies improve the efficacy of pulmonary vein isolation in non-paroxysmal atrial fibrillation: a systematic review and meta-analysis.What Is the Appropriate Lesion Set for Ablation in Patients with Persistent Atrial Fibrillation?

P2860

Q26864767-80EEEAD3-471C-445D-998D-99609F70D184 Q28073160-4E1E3005-7272-4A8E-9EB0-0E1E0A5095F4 Q28074710-64B18808-8095-4156-8445-4D94BFCA8FDE Q28084012-80F7B6CD-D73F-4F20-A462-5A93B0B338AB Q30318198-1F75DFED-71FB-493B-94E7-6D62FDC4258A Q33789048-EFA63737-76C0-4E7E-8863-FC5640E653CA Q33941583-F9552700-A8D5-49C8-9587-30CAB19B0F08 Q34472307-2C5BA540-3009-411A-B73C-D56C631196A9 Q34505587-BF9650AE-77B9-4A80-97BC-D2C497FEB83C Q35059670-7C59F045-39DA-464F-B90B-F7C42EAE5CC6 Q35212904-95C0ECE7-09C8-40F6-A179-5D489693CF37 Q35773242-7854BDFD-4CAA-48A0-AE9F-7778ECAB2430 Q35855849-3A9CC80E-3EAB-42CE-A223-EF974364DD10 Q35914686-11028A7C-D8F5-4BF7-8D98-143BD8ED370D Q35971046-85731048-6257-436D-BB73-3A6A47EFBD41 Q36072140-63B18D08-BE87-487B-8889-5CD852850D97 Q36169327-267721CA-A4A1-46AC-BD46-258C6D84272F Q36170147-07FD7381-EB6C-46A0-901A-769E33163CAC Q36283008-E1893297-1EA1-441A-93B6-FA310A4A4815 Q36418765-394DC533-7859-4E81-AD04-412119FA9981 Q36458809-E9EBC7B6-944F-4B7D-812E-28269FE3D630 Q37348493-E2F3928D-E881-408E-8261-5CC1A811E645 Q37434640-0F113418-A167-4415-9D76-B2A952411EE4 Q37495629-A059B9AF-3620-4E99-A9AF-7763CEA39E38 Q37495724-B0943C05-1A69-4DBB-97DC-FF7821788829 Q37622130-55677EC9-2361-46D4-AF2B-E7FE965BB180 Q37952821-B9C45387-F82A-46F8-8F44-6EB074CF2801 Q37994844-65ABCD9A-AAA4-41ED-ADF9-2B8BC93BECAB Q38037667-15A277F0-0C3F-447E-81C3-F09B82C2D963 Q38041202-5806FBAF-D1F1-426D-93F4-19DAFCBCE519 Q38051103-18E134F6-0A37-43A8-9498-161762FE9FC5 Q38067776-3352A47A-BF16-413D-B648-80AD01B6CA4C Q38131689-AA057100-1D35-442E-892A-6C782A67A31A Q38258667-18F11F33-AF90-4D47-9475-B910610B68F2 Q38790580-48EE3992-D039-4A8C-B9B3-45784D3383BB Q38938517-E680D5AF-9726-44AE-BFB6-B000E59327A5 Q39037023-2861CDFD-C426-45F7-BACF-42E35FB24F43 Q39119910-9377D7FC-91D4-4A75-9F90-C6E1A0601AFA Q39159567-68BF461B-0CC9-4ED4-92DF-BCCDC5DA8F9E Q39236932-50A486C2-6C8B-4DAE-B1DE-6D91089DE80B

P2860

Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial.

http://www.wikidata.org/entity/Q33886896

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Substrate and Trigger Ablation ...... ticentre, international trial.

@ast

Substrate and Trigger Ablation ...... ticentre, international trial.

@en

type

label

Substrate and Trigger Ablation ...... ticentre, international trial.

@ast

Substrate and Trigger Ablation ...... ticentre, international trial.

@en

prefLabel

Substrate and Trigger Ablation ...... ticentre, international trial.

@ast

Substrate and Trigger Ablation ...... ticentre, international trial.

@en

P1433

Q33886896-3F2FD75A-20B2-42EA-91B3-3F5106EFDC91

P1476

Q33886896-2EC84C7F-9D9F-4DE2-B3C7-A81997F68F03

P2093

Q33886896-1165CCF3-C91C-4D57-9743-FA071E6B5375

Q33886896-235904E4-2CD1-493B-9DD9-2B1EAB637EBE

Q33886896-2378CE01-2A6A-498D-9EC4-170333B7870B

Q33886896-39149799-E75A-4C7D-BC71-83B9E71776C3

Q33886896-39AD9346-E304-4799-9675-9CFE77707130

Q33886896-49030F92-183B-46B0-9CFC-12E2BB8A2B25

Q33886896-6ED31D27-85FA-4E7B-80E2-98EFF033717B

Q33886896-772DA847-CFBD-4F8D-922C-9F24784168BA

Q33886896-B67A5494-97CA-4BC7-B300-557D9A6C04F5

Q33886896-C43E5903-BD2D-4A56-A3BD-5F5E14A049B9

P2860

Q33886896-013C2753-3876-4C4C-9CAE-15DA92B9949B

Q33886896-061CF4B2-A228-4DA7-A671-E4FBED6CE8D4

Q33886896-13E2B4D0-469F-4EF2-8161-F2BCD2E43F1A

Q33886896-20BC15E6-9EB5-4120-B3A5-68698AF21769

Q33886896-332A7522-D1DB-425B-9A2D-F61CD3066D5F

Q33886896-3E6A01D1-B216-4349-A2D5-563478B66D11

Q33886896-3F5F587C-790D-4E9D-9B2A-19E0042AB4EC

Q33886896-5A006483-B82F-47AC-B78D-E14AEF936DFC

Q33886896-907A8945-3971-49F8-9693-96BEAD3BC996

Q33886896-934C78E3-8DF5-46E8-82F1-D7E1FD405392

P304

Q33886896-6DACA784-98C3-444B-9D58-05DA5E8082A8

P31

Q33886896-D954A12F-713D-4C69-B716-9AFC8A624CFE

P356

Q33886896-18796276-F011-41F1-AE69-F381AD247E4D

P433

Q33886896-F6637B55-39E3-4120-B5BC-661BE5778513

P478

Q33886896-4D5AB5BC-701A-46C2-AF13-286AA7BDFAF3

P577

Q33886896-8572B4C2-2A37-44C4-99D6-ED17A1E83ADC

P5875

Q33886896-2DFA5DB6-5DA9-4D0D-B8B6-E626AC5D094D

P698

Q33886896-B5FDF212-BD9F-47E8-A12B-CB613FA25E72

P921

Q33886896-19341BBE-4696-4A26-BE18-9AA291F40CEC

Q33886896-C72B43B2-D847-4DF1-B57C-4DCAE07A1618

P932

Q33886896-3ECCD603-095C-4C8F-8BD7-1469D6DCD512

P356

P1433

European Heart Journal

P1476

Substrate and Trigger Ablation ...... ticentre, international trial.

@en

P2093

Atul Verma

http://www.w3.org/2001/XMLSchema#string

Carlos A Morillo

http://www.w3.org/2001/XMLSchema#string

Esteban G Torrecilla

http://www.w3.org/2001/XMLSchema#string

Girish Nair

http://www.w3.org/2001/XMLSchema#string

Guiseppe De Martino

http://www.w3.org/2001/XMLSchema#string

Jian Chen

http://www.w3.org/2001/XMLSchema#string

Laurent Macle

http://www.w3.org/2001/XMLSchema#string

Paul Novak

http://www.w3.org/2001/XMLSchema#string

Peter G Guerra

http://www.w3.org/2001/XMLSchema#string

Roberto Mantovan

http://www.w3.org/2001/XMLSchema#string

P2860

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up

Ablation for longstanding permanent atrial fibrillation: results from a randomized study comparing three different strategies.

Mother rotors and fibrillatory conduction: a mechanism of atrial fibrillation.

Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation.

Fractionation of electrograms and linking of activation during pharmacologic cardioversion of persistent atrial fibrillation in the goat.

A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate.

Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation.

A randomized assessment of the incremental role of ablation of complex fractionated atrial electrograms after antral pulmonary vein isolation for long-lasting persistent atrial fibrillation.

Response of atrial fibrillation to pulmonary vein antrum isolation is directly related to resumption and delay of pulmonary vein conduction.

P304

1344-1356

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHQ041

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41848369

http://www.w3.org/2001/XMLSchema#string

P698

20215126

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

atrial fibrillation

P932

2878965

http://www.w3.org/2001/XMLSchema#string